305 related articles for article (PubMed ID: 8995942)
1. Nasogastric omeprazole: effects on gastric pH in critically Ill patients.
Balaban DH; Duckworth CW; Peura DA
Am J Gastroenterol; 1997 Jan; 92(1):79-83. PubMed ID: 8995942
[TBL] [Abstract][Full Text] [Related]
2. A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers.
Phillips JO; Olsen KM; Rebuck JA; Rangnekar NJ; Miedema BW; Metzler MH
Am J Gastroenterol; 2001 Feb; 96(2):367-72. PubMed ID: 11232677
[TBL] [Abstract][Full Text] [Related]
3. Failure of nasogastric omeprazole suspension in pediatric intensive care patients.
Haizlip JA; Lugo RA; Cash JJ; Vernon DD
Pediatr Crit Care Med; 2005 Mar; 6(2):182-7. PubMed ID: 15730606
[TBL] [Abstract][Full Text] [Related]
4. Nonencapsulated, intact omeprazole granules effectively suppress intragastric acidity when administered via a gastrostomy.
Sharma VK; Heinzelmann EJ; Steinberg EN; Vasudeva R; Howden CW
Am J Gastroenterol; 1997 May; 92(5):848-51. PubMed ID: 9149199
[TBL] [Abstract][Full Text] [Related]
5. The effect of omeprazole paste on intragastric pH in clinically ill neonatal foals.
Javsicas LH; Sanchez LC
Equine Vet J; 2008 Jan; 40(1):41-4. PubMed ID: 18083658
[TBL] [Abstract][Full Text] [Related]
6. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
7. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
[TBL] [Abstract][Full Text] [Related]
8. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
Leite LP; Johnston BT; Just RJ; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
[TBL] [Abstract][Full Text] [Related]
9. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
Miner PB; Allgood LD; Grender JM
Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
[TBL] [Abstract][Full Text] [Related]
10. Simplified lansoprazole suspension--a liquid formulation of lansoprazole--effectively suppresses intragastric acidity when administered through a gastrostomy.
Sharma VK; Vasudeva R; Howden CW
Am J Gastroenterol; 1999 Jul; 94(7):1813-7. PubMed ID: 10406240
[TBL] [Abstract][Full Text] [Related]
11. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
12. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer.
Sheu BS; Chi CH; Yang HB; Jen CM; Lin XZ
Hepatogastroenterology; 1999; 46(28):2363-71. PubMed ID: 10521999
[TBL] [Abstract][Full Text] [Related]
13. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls.
Kuo B; Castell DO
Am J Gastroenterol; 1996 Aug; 91(8):1532-8. PubMed ID: 8759656
[TBL] [Abstract][Full Text] [Related]
14. Cimetidine versus antacids in the prevention of stress erosions in critically ill patients.
Poleski MH; Spanier AH
Am J Gastroenterol; 1986 Feb; 81(2):107-11. PubMed ID: 3946364
[TBL] [Abstract][Full Text] [Related]
15. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.
Naesdal J; Bodemar G; Walan A
Scand J Gastroenterol; 1984 Oct; 19(7):916-22. PubMed ID: 6531660
[TBL] [Abstract][Full Text] [Related]
16. Nasogastric lansoprazole is effective in suppressing gastric acid secretion in critically ill patients.
Tsai WL; Poon SK; Yu HK; Chang CS; Yeh HZ; Ko CW; Chen GH
Aliment Pharmacol Ther; 2000 Jan; 14(1):123-7. PubMed ID: 10632655
[TBL] [Abstract][Full Text] [Related]
17. The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids.
Bonten MJ; Gaillard CA; van der Geest S; van Tiel FH; Beysens AJ; Smeets HG; Stobberingh EE
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1825-34. PubMed ID: 8520743
[TBL] [Abstract][Full Text] [Related]
18. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
[TBL] [Abstract][Full Text] [Related]
19. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Netzer P; Gaia C; Sandoz M; Huluk T; Gut A; Halter F; Hüsler J; Inauen W
Am J Gastroenterol; 1999 Feb; 94(2):351-7. PubMed ID: 10022628
[TBL] [Abstract][Full Text] [Related]
20. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]